Merit increase for 2024??






















Expect a Merit Raise of 4% and a Bonus Multiplier of 75%. Overall net savings. Their way of slowly phasing out the bonus program. Thank-you Ashley for setting the precedent in February 2023. That move saved MedTech $1B. I want my $5,000 back. After you leave we will remember you in our dreams. Face it you know that you were never qualified for your position; you were a D&I checkmark. Let’s see where (if) you land in 2024 based on your J&J record of success and accomplishments such as ASP and Robotics.
 


Expect a Merit Raise of 4% and a Bonus Multiplier of 75%. Overall net savings. Their way of slowly phasing out the bonus program. Thank-you Ashley for setting the precedent in February 2023. That move saved MedTech $1B. I want my $5,000 back. After you leave we will remember you in our dreams. Face it you know that you were never qualified for your position; you were a D&I checkmark. Let’s see where (if) you land in 2024 based on your J&J record of success and accomplishments such as ASP and Robotics.

Right, there are many great female J&J leaders but she was not one of them. Now she ruined it for the rest of us.
 


Expect a Merit Raise of 4% and a Bonus Multiplier of 75%. Overall net savings. Their way of slowly phasing out the bonus program. Thank-you Ashley for setting the precedent in February 2023. That move saved MedTech $1B. I want my $5,000 back. After you leave we will remember you in our dreams. Face it you know that you were never qualified for your position; you were a D&I checkmark. Let’s see where (if) you land in 2024 based on your J&J record of success and accomplishments such as ASP and Robotics.

looking forward to my Jelly of the Month
 


Expect a Merit Raise of 4% and a Bonus Multiplier of 75%. Overall net savings. Their way of slowly phasing out the bonus program. Thank-you Ashley for setting the precedent in February 2023. That move saved MedTech $1B. I want my $5,000 back. After you leave we will remember you in our dreams. Face it you know that you were never qualified for your position; you were a D&I checkmark. Let’s see where (if) you land in 2024 based on your J&J record of success and accomplishments such as ASP and Robotics.

A multipler lower than the last one would likely be the final straw for a bunch of folks TBH. Already burdened with taking on MORE work with all the layoffs this year.

And they wonder why the credo results are poor…
 


Big WSJ article today about who is next in line and Ashley’s departure. Interview where she said she wanted to be CEO did not go over well. Taubert and Wolk top contenders.
 








I noticed that there are some senior manager postings, as well as some associate Director postings. What’s the strategy behind the two different titles?

At J&J, Sr. Manager and Associate Director are the same pay grade. Generally, Pharma and some other pockets within marketing have used the AD title for the same pay grade.
 





Write your reply...